表紙
市場調查報告書
商品編碼
1064878

生物學治療藥的全球市場(2021年∼2027年)

Global Biologic Therapeutics Drugs Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球生物學治療藥的市場規模,在預測期間內預計以可觀的年複合成長率成長。牽引這個市場的主要原因,有癌症,糖尿病,CVD等慢性疾病的盛行率上升等。

本報告提供生物學治療藥市場調查,市場概要,市場的推動因素與阻礙因素的分析,市場機會,各產品類型,各用途,各地區的市場分析,主要企業的簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 市場細分化

  • 全球生物學治療藥市場:各產品類型
    • 血液、血液製劑
    • 疫苗
    • 人細胞、組織
    • 細胞治療
    • 過敏原萃取物
    • 基因治療
    • 其他
  • 全球生物學治療藥市場:各用途
    • 類風濕性關節炎
    • 貧血
    • 癌症
    • 糖尿病
    • 其他

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第6章 企業簡介

  • Pfizer Inc.
  • AstraZeneca Plc
  • Novartis International AG
  • Merck & Co., Inc.
  • GlaxoSmithKline PlC
目錄
Product Code: OMR2024374

Global Biologic Therapeutics Drugs Market Size, Share & Trends Analysis Report, By Product (Blood and Blood Products, Vaccines, Human Cells and Tissues, Cellular Therapies, Allergenic Extracts, Gene Therapies, and Others), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes and Others), and Forecast (2021-2027)

The global biologic therapeutics drug market is anticipated to grow at a considerable CAGR during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of chronic disorders, including cancer, diabetes, and CVD. According to the World Health Organization (WHO), in 2020, the new cancer incidences reported was 19.3 million. Breast cancer was the most common cancer type in 2020 with almost 2.3 million cases, followed by lung cancer with 2.2 million cases, colon and rectum cancer with 1.9 million cases, prostate cancer with 1.4 million cases, and stomach cancer with 1.1 million cases.

The global biologic therapeutics drug market is segmented based on type and application. Based on type, the biologic therapeutics drug market is segmented into blood and blood products, vaccines, human cells and tissues, cellular therapies, allergenic extracts, gene therapies, and others. Based on application, the biologic therapeutics drug market is segmented into rheumatoid arthritis, anemia, cancer, diabetes and others.

Geographically, the global biologic therapeutics drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global biologic therapeutics drug market include Pfizer Inc., AstraZeneca Plc, Novartis International AG, Merck & Co., Inc, and GlaxoSmithKline Plc.

Market Segmentation

1. Global Biologic therapeutics drug market Research and Analysis by Type

2. Global Biologic therapeutics drug market Research and Analysis by Application

The Report Covers

  • Comprehensive research methodology of the global biologic therapeutics drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global biologic therapeutics drug market.
  • Insights about market determinants that are stimulating the global biologic therapeutics drug market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Biologic Therapeutics Drug Market by Product Type
    • 4.1.1. Blood and Blood Products
    • 4.1.2. Vaccines
    • 4.1.3. Human Cells & Tissues
    • 4.1.4. Cellular Therapies
    • 4.1.5. Allergenic Extracts
    • 4.1.6. Gene Therapies
    • 4.1.7. Others
  • 4.2. Global Biologic Therapeutics Drug Market by Application
    • 4.2.1. Rheumatoid Arthritis
    • 4.2.2. Anemia
    • 4.2.3. Cancer
    • 4.2.4. Diabetes
    • 4.2.5. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Pfizer Inc.
  • 6.2. AstraZeneca Plc
  • 6.3. Novartis International AG
  • 6.4. Merck & Co., Inc.
  • 6.5. GlaxoSmithKline PlC

LIST OF TABLES

  • 1. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL BLOOD AND BLOOD PRODUCTS FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL VACCINES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL HUMAN CELLS & TISSUES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL CELLULAR THERAPIES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ALLERGENIC EXTRACTS FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL GENE THERAPIES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL OTHER TYPE BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 10. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR ANEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 19. EUROPEAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. EUROPEAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 21. EUROPEAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 25. REST OF THE WORLD BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)